Guidelines – Page 5 – Policy & Medicine

FDA Releases Draft Guidance on Biosimilar Review

DEA Amends Regulations Applicable to Registrants Ordering Certain Controlled Substances

FDA Releases Two Draft Guidances on REMS Programs

FDA Announces New Efforts to Hold Industry Accountable for Fulfilling Post-Marketing Studies

Medscape Releases 2018 Ethics Report

CDC Releases a Guide on Implementing Opioid Guidelines – But Is A Showdown With the FDA Looming?

FDA to Study Disclosures in Prescription Drug Advertisements

FDA Issues New Draft Guidance on Submitting Formal Meeting Requests

New Limitations on Guidance Documents Expected to Have Heavy Effect on Industry

FDA Releases Guidance on IND Sponsors